Cargando…
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
AIMS: Metformin exerts anti-inflammatory and immunosuppressive effects. We addressed the impact of prior metformin use on prognosis in patients with type 2 diabetes hospitalised for COVID-19. METHODS: CORONADO is a nationwide observational study that included patients with diabetes hospitalised for...
Autores principales: | Lalau, Jean-Daniel, Al-Salameh, Abdallah, Hadjadj, Samy, Goronflot, Thomas, Wiernsperger, Nicolas, Pichelin, Matthieu, Allix, Ingrid, Amadou, Coralie, Bourron, Olivier, Duriez, Thierry, Gautier, Jean-François, Dutour, Anne, Gonfroy, Céline, Gouet, Didier, Joubert, Michael, Julier, Ingrid, Larger, Etienne, Marchand, Lucien, Marre, Michel, Meyer, Laurent, Olivier, Frédérique, Prevost, Gaëtan, Quiniou, Pascale, Raffaitin-Cardin, Christelle, Roussel, Ronan, Saulnier, Pierre-Jean, Seret-Begue, Dominique, Thivolet, Charles, Vatier, Camille, Desailloud, Rachel, Wargny, Matthieu, Gourdy, Pierre, Cariou, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832745/ https://www.ncbi.nlm.nih.gov/pubmed/33309936 http://dx.doi.org/10.1016/j.diabet.2020.101216 |
Ejemplares similares
-
Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study
por: Cariou, Bertrand, et al.
Publicado: (2021) -
La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19
por: Lalau, Jean-Daniel, et al.
Publicado: (2021) -
Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study
por: Wargny, Matthieu, et al.
Publicado: (2020) -
Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative
por: Cariou, Bertrand, et al.
Publicado: (2022) -
Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399–1407
por: Cariou, Bertrand, et al.
Publicado: (2020)